Homepage
Author:
Trogenix
Posted Date:
May 29, 2026
Trogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma
Trogenix
May 29, 2026
Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model
Trogenix
May 23, 2026
